Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Erkki, Wuolijoki"'
Autor:
Erkki Wuolijoki, Jaakko Keranen, Tuomo Nieminen, Ilkka Kallela, Heikki Kainulainen, Ilmari Hiidenheimo, Immo Rantala
Publikováno v:
International Journal of Oral and Maxillofacial Surgery. 35:727-732
The aim of this study was to assess degradation of a novel bioactive guided tissue regeneration (GTR) membrane and to quantify the concurrent tissue responses. Pieces of membrane composed of poly-l-lactide, poly-d,l-lactide, trimethylenecarbonate and
Autor:
Erkki Wuolijoki, Riikka Rontu, Mikko Hurme, Petri Ojala, Hannu Jokela, Marja Jylhä, Pekka J. Karhunen, Terho Lehtimäki, Saara Metso, and Antti Hervonen Md, Sirkka Goebeler, Matti Nikkilä, Kari Mattila
Publikováno v:
Journal of the American Geriatrics Society. 53:1552-1558
OBJECTIVES: To establish whether the relationship between interleukin-6 (IL-6) and plasma lipid and C-reactive protein (CRP) concentrations is different in Finnish nonagenarians than in middle-aged subjects with lower inflammatory status. DESIGN: Cro
Autor:
Erkki Wuolijoki, Riikka Rontu, Terho Lehtimäki, Saara Metso, Pauli Ylitalo, Ritva Ylitalo, Matti Nikkil
Publikováno v:
Basic Toxicology. 97:98-103
Chitosan is a deacetylated product of chitin. Microcrystalline form of chitosan has a large adsorption area claimed to decrease gastrointestinal absorption of cholesterol. However, the long-term effect of chitosan on plasma lipids is variable, the av
Publikováno v:
European Journal of Clinical Pharmacology. 59:741-746
To evaluate the long-term effect of microcrystalline chitosan (MCC) on plasma lipids, especially the concentration of low-density lipoprotein (LDL) cholesterol, in subjects with a moderately increased concentration of plasma total cholesterol. A tota
Publikováno v:
Contemporary clinical trials. 32(3)
Objectives To develop an in-house training program of Good Clinical Practice (GCP) for the whole clinical team and to evaluate the effect of the program on the personnel's knowledge on GCP. Background GCP is a set of ethical and scientific quality re
Autor:
Ilmari Hiidenheimo, Heikki Kainulainen, Erkki Wuolijoki, Immo Rantala, Ilkka Kallela, Tuomo Nieminen
Publikováno v:
Journal of biomedical materials research. Part A. 84(2)
The study was aimed to test the mechanical strength, structural stability, and tissue reactions of optically amorphous and crystalline polyetheretherketone (PEEK) plates during a 3-year follow-up in vivo and in vitro. The injection-moulded PEEK plate
Autor:
Ilkka Kallela, Heikki Kainulainen, Immo Rantala, Erkki Wuolijoki, Ilmari Hiidenheimo, Tuomo Nieminen, Jaakko Keranen
Publikováno v:
Journal of materials science. Materials in medicine. 19(3)
We tested the tissue reactions and mechanical strength of a novel biodegradable craniomaxillofacial plating system, Inion CPS™, in the course of degradation. Plates and screws composed of l-lactide, d-lactide and trimethylene carbonate were implant
Autor:
Mari Luomala, Juha Laakso, Inkeri Ruokonen, Reijo Laaksonen, Matti Nikkilä, Saara Metso, Hannu Päivä, Tiina Solakivi, Erkki Wuolijoki, Marika Saarela, Terho Lehtimäki
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 371(1-2)
Background Oxidative modification of low-density lipoprotein (LDL) is an important contributor to atherosclerosis. Also, oxidized LDL is suspected to cause accumulation of asymmetric dimethylarginine (ADMA), an endogenous competitive nitric oxide syn
Autor:
Terho, Lehtimäki, Petri, Ojala, Riikka, Rontu, Sirkka, Goebeler, Pekka J, Karhunen, Marja, Jylhä, Kari, Mattila, Saara, Metso, Hannu, Jokela, Matti, Nikkilä, Erkki, Wuolijoki, Antti, Hervonen, Mikko, Hurme
Publikováno v:
Journal of the American Geriatrics Society. 53(9)
To establish whether the relationship between interleukin-6 (IL-6) and plasma lipid and C-reactive protein (CRP) concentrations is different in Finnish nonagenarians than in middle-aged subjects with lower inflammatory status.Cross-sectional.Observat
Autor:
Reijo Laaksonen, Erkki Wuolijoki, Saara Metso, Inkeri Ruokonen, Juha Laakso, Hannu Päivä, Matti Nikkilä, Riitta Tervonen, Terho Lehtimäki
Publikováno v:
Metabolism: clinical and experimental. 53(8)
Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase inhibitor that participates in the regulation of vasodilatory function and is also linked to hypertension, whereas its stereoisomere, symmetric dimethylarginine (SDMA), is biol